Preterm Neonatal Feeding Protocol Comparing Feed Administration Time
NCT ID: NCT00997854
Last Updated: 2019-06-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
136 participants
INTERVENTIONAL
2009-10-31
2010-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of this study is to test two different methods of feeding preterm babies in the hopes of identifying a method that will decrease some of the feeding intolerance that can occur when feeding premature babies.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Feeding Tolerance in Preterm Infants
NCT00450697
Feeding Intolerance in Preterm Infant
NCT06693557
Hydrolized Protein Formula for Premature Infants
NCT01156493
Impact of Modified Feeding Protocol on Neonatal Outcomes
NCT06246032
Adjusted Individual Oral Feeding for Improving Short and Long Term Outcomes of Preterm Infants
NCT01989871
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1 Bolus Feeds
This group will receive feeds administered by bolus method over no more than 30 minutes per feed.
Length of time for feed administration
Group 1 will consist of babies fed by bolus method, administered over no more than 30 minutes. Group 2 will be fed by slow infusion by pump over 2 hours.
Group 2- Slow Infusion Feeds
This group will receive feeds administered by slow infusion over pump for 2 hours.
Length of time for feed administration
Group 1 will consist of babies fed by bolus method, administered over no more than 30 minutes. Group 2 will be fed by slow infusion by pump over 2 hours.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Length of time for feed administration
Group 1 will consist of babies fed by bolus method, administered over no more than 30 minutes. Group 2 will be fed by slow infusion by pump over 2 hours.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* omphalocele
* bowel obstruction or atresia
* tracheo-esophageal fistula
* Hirschsprung's Disease
* congenital diaphragmatic hernia
* congenital heart disease and other major syndromes
* infants who have started enteral feeds prior to entering the study
* Any infant whose birth weight is greater than or equal to 1500 grams or less than 500 grams
* Any infant whose gestational age is greater than 32 weeks.
32 Weeks
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oregon Health and Science University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sue Ann Smith
MD, Neonatologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sue Ann Smith, MD
Role: PRINCIPAL_INVESTIGATOR
Oregon Health and Science University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oregon Health & Sciences University
Portland, Oregon, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5376
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.